Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedUI changes on the Study Record History page introduce a glossary, color-coded highlights (green for additions, red for deletions), and the revision label Revision: v3.4.0, while removing the No FEAR Act data note and the older Revision: v3.3.4 label.SummaryDifference0.6%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page history shows a new revision v3.3.4 has been added and the previous revision v3.3.3 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedLatest version entries in the Record History (around 2025-11-28 and 2025-12-05) include updates to the Study Status section for NCT03459846.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision: v3.3.2 is now shown in the Record History, replacing the previous v3.3.1 entry.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page history shows a new site revision v3.3.1 added and v3.2.0 removed. This is a minor system update that does not change core study data or trial content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.